Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1
Carolina Mendonça Gorgulho, Graziela Gorete Romagnoli, Rosh Bharthi, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling
Sei‐ichi Tanuma, Takahiro Oyama, Miwa Okazawa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3426-3426
Open Access | Times Cited: 10
SHP2 inhibitor PHPS1 ameliorates acute kidney injury by Erk1/2-STAT3 signaling in a combined murine hemorrhage followed by septic challenge model
Jihong Jiang, Baoji Hu, Chun‐Shiang Chung, et al.
Molecular Medicine (2020) Vol. 26, Iss. 1
Open Access | Times Cited: 15
Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
Tong Lin, Yingzhao Zhang, Zhimei Lin, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 13
Role of Base Excision Repair in Innate Immune Cells and Its Relevance for Cancer Therapy
Shengyuan Zhao, Samy L. Habib, Alireza G. Senejani, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 557-557
Open Access | Times Cited: 9
Challenges in tendon–bone healing: emphasizing inflammatory modulation mechanisms and treatment
Fan Jiang, Haibo Zhao, Po Zhang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Different measures of HMGB1 location in cancer immunology
Carolina Mendonça Gorgulho, Pranav Murthy, Lance Liotta, et al.
Methods in enzymology on CD-ROM/Methods in enzymology (2019), pp. 195-217
Closed Access | Times Cited: 11
Extracellular HMGB-1 activates inflammatory signaling in tendon cells and tissues
Chuanxin Zhang, Xin-Feng Gu, Guangyi Zhao, et al.
Therapeutic Advances in Chronic Disease (2020) Vol. 11
Open Access | Times Cited: 10
Myeloid cells in sensing of tissue damage
Carlos del Fresno, David Sancho
Current Opinion in Immunology (2020) Vol. 68, pp. 34-40
Open Access | Times Cited: 10
Role of RAGE and its ligand HMGB1 in the development of COPD
Lin Chen, Xuejiao Sun, Xiaoning Zhong
Postgraduate Medicine (2022) Vol. 134, Iss. 8, pp. 763-775
Closed Access | Times Cited: 6
CagA+Helicobacter pylori infection and N‐nitrosodimethylamine administration induce cholangiocarcinoma development in hamsters
Rungtiwa Dangtakot, Kitti Intuyod, Yaovalux Chamgramol, et al.
Helicobacter (2021) Vol. 26, Iss. 4
Closed Access | Times Cited: 8
High mobility group box 1 in women with unexplained recurrent pregnancy loss
Carlo Ticconi, Stefania Mardente, Emanuela Mari, et al.
Journal of Perinatal Medicine (2023) Vol. 51, Iss. 9, pp. 1139-1146
Closed Access | Times Cited: 3
Gutting it Out: Developing Effective Immunotherapies for Patients With Colorectal Cancer
Carolina Mendonça Gorgulho, Anuradha Krishnamurthy, Anastasia Lanzi, et al.
Journal of Immunotherapy (2021) Vol. 44, Iss. 2, pp. 49-62
Open Access | Times Cited: 7
Discovery of 5,5′-Methylenedi-2,3-Cresotic Acid as a Potent Inhibitor of the Chemotactic Activity of the HMGB1·CXCL12 Heterocomplex Using Virtual Screening and NMR Validation
Federica De Leo, Giacomo Quilici, Francesco De Marchis, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 7
A peaceful death orchestrates immune balance in a chaotic environment
Adam C. Soloff, Michael T. Lotze
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 46, pp. 22901-22903
Open Access | Times Cited: 6
NOX2 decoy peptides disrupt trauma-mediated neutrophil immunosuppression and protect against lethal peritonitis
Maroof Husain, Eugene Becker, Nathaniel B. Bone, et al.
Redox Biology (2020) Vol. 36, pp. 101651-101651
Open Access | Times Cited: 6
HMGB1 Promotes Myeloid Egress and Limits Lymphatic Clearance of Malignant Pleural Effusions
Adam C. Soloff, Katherine E. Jones, Amy Powers, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 4
Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States–Based Subtyping in Bladder Cancer
Rixin Hu, Tao Tao, Yu Lu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 3
Angiogenesis in Wound Healing following Pharmacological and Toxicological Exposures
Russell Hunter, Katie T. Kivlighan, Sharon L. Ruyak, et al.
Current Pathobiology Reports (2020) Vol. 8, Iss. 4, pp. 99-109
Closed Access | Times Cited: 3
Late Inflammation Induced by Asbestiform Fibers in Mice Is Ameliorated by a Small Molecule Synthetic Lignan
Reagan Badger, Kyewon Park, Ralph A. Pietrofesa, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 10982-10982
Open Access | Times Cited: 3
Discovery of 5,5’-methylenedi-2,3-cresotic acid as a potent inhibitor of chemotactic activity of the HMGB1•CXCL12 heterocomplex using Virtual Screening and NMR validation
Federica De Leo, Giacomo Quilici, Francesco De Marchis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
THE ROLE OF GLI3 IN INFLAMMATION
Stephan J. Matissek
(2020)
Closed Access
Previous Page - Page 2

Scroll to top